Sex and Gender Differences in the Effects of Novel Psychoactive Substances

Sex and gender deeply affect the subjective effects and pharmaco-toxicological responses to drugs. Men are more likely than women to use almost all types of illicit drugs and to present to emergency departments for serious or fatal intoxications. However, women are just as likely as men to develop s...

Full description

Bibliographic Details
Main Authors: Liana Fattore, Matteo Marti, Rafaela Mostallino, Maria Paola Castelli
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/10/9/606
_version_ 1797554717812850688
author Liana Fattore
Matteo Marti
Rafaela Mostallino
Maria Paola Castelli
author_facet Liana Fattore
Matteo Marti
Rafaela Mostallino
Maria Paola Castelli
author_sort Liana Fattore
collection DOAJ
description Sex and gender deeply affect the subjective effects and pharmaco-toxicological responses to drugs. Men are more likely than women to use almost all types of illicit drugs and to present to emergency departments for serious or fatal intoxications. However, women are just as likely as men to develop substance use disorders, and may be more susceptible to craving and relapse. Clinical and preclinical studies have shown important differences between males and females after administration of “classic” drugs of abuse (e.g., Δ9-tetrahydrocannabinol (THC), morphine, cocaine). This scenario has become enormously complicated in the last decade with the overbearing appearance of the new psychoactive substances (NPS) that have emerged as alternatives to regulated drugs. To date, more than 900 NPS have been identified, and can be catalogued in different pharmacological categories including synthetic cannabinoids, synthetic stimulants (cathinones and amphetamine-like), hallucinogenic phenethylamines, synthetic opioids (fentanyls and non-fentanyls), new benzodiazepines and dissociative anesthetics (i.e., methoxetamine and phencyclidine-derivatives). This work collects the little knowledge reached so far on the effects of NPS in male and female animal and human subjects, highlighting how much sex and gender differences in the effects of NPS has yet to be studied and understood.
first_indexed 2024-03-10T16:36:01Z
format Article
id doaj.art-8e9421f77094438891e6b281b0e9af8e
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-10T16:36:01Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-8e9421f77094438891e6b281b0e9af8e2023-11-20T12:28:34ZengMDPI AGBrain Sciences2076-34252020-09-0110960610.3390/brainsci10090606Sex and Gender Differences in the Effects of Novel Psychoactive SubstancesLiana Fattore0Matteo Marti1Rafaela Mostallino2Maria Paola Castelli3Institute of Neuroscience-Cagliari, National Research Council (CNR), Cittadella Universitaria, 09042 Monserrato, Cagliari, ItalyDepartment of Morphology, Surgery and Experimental Medicine, Section of Legal Medicine and LTTA Center, University of Ferrara, 44121 Ferrara, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cittadella Universitaria, 09042 Monserrato, Cagliari, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cittadella Universitaria, 09042 Monserrato, Cagliari, ItalySex and gender deeply affect the subjective effects and pharmaco-toxicological responses to drugs. Men are more likely than women to use almost all types of illicit drugs and to present to emergency departments for serious or fatal intoxications. However, women are just as likely as men to develop substance use disorders, and may be more susceptible to craving and relapse. Clinical and preclinical studies have shown important differences between males and females after administration of “classic” drugs of abuse (e.g., Δ9-tetrahydrocannabinol (THC), morphine, cocaine). This scenario has become enormously complicated in the last decade with the overbearing appearance of the new psychoactive substances (NPS) that have emerged as alternatives to regulated drugs. To date, more than 900 NPS have been identified, and can be catalogued in different pharmacological categories including synthetic cannabinoids, synthetic stimulants (cathinones and amphetamine-like), hallucinogenic phenethylamines, synthetic opioids (fentanyls and non-fentanyls), new benzodiazepines and dissociative anesthetics (i.e., methoxetamine and phencyclidine-derivatives). This work collects the little knowledge reached so far on the effects of NPS in male and female animal and human subjects, highlighting how much sex and gender differences in the effects of NPS has yet to be studied and understood.https://www.mdpi.com/2076-3425/10/9/606NPSsex/gender differencescannabinoidscathinonesphenethylaminesopioids
spellingShingle Liana Fattore
Matteo Marti
Rafaela Mostallino
Maria Paola Castelli
Sex and Gender Differences in the Effects of Novel Psychoactive Substances
Brain Sciences
NPS
sex/gender differences
cannabinoids
cathinones
phenethylamines
opioids
title Sex and Gender Differences in the Effects of Novel Psychoactive Substances
title_full Sex and Gender Differences in the Effects of Novel Psychoactive Substances
title_fullStr Sex and Gender Differences in the Effects of Novel Psychoactive Substances
title_full_unstemmed Sex and Gender Differences in the Effects of Novel Psychoactive Substances
title_short Sex and Gender Differences in the Effects of Novel Psychoactive Substances
title_sort sex and gender differences in the effects of novel psychoactive substances
topic NPS
sex/gender differences
cannabinoids
cathinones
phenethylamines
opioids
url https://www.mdpi.com/2076-3425/10/9/606
work_keys_str_mv AT lianafattore sexandgenderdifferencesintheeffectsofnovelpsychoactivesubstances
AT matteomarti sexandgenderdifferencesintheeffectsofnovelpsychoactivesubstances
AT rafaelamostallino sexandgenderdifferencesintheeffectsofnovelpsychoactivesubstances
AT mariapaolacastelli sexandgenderdifferencesintheeffectsofnovelpsychoactivesubstances